Pyr-Pro-Arg-pNA
Pyr-Pro-Arg-pNA (S-2366) is a chromogenic peptidyl substrate, and a noncompetitive inhibitor that occupies the active sites of FXIa and FXIa-LC to block factor IX activation. Pyr-Pro-Arg-pNA functions as a hydrolyzable substrate for FXIa’s catalytic domain, human APC, murine APC, and purified plasma kallikrein.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 72194-57-1
- Formel: C22H30N8O6
- Molecular Weight:502.52
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Pyr-Pro-Arg-pNA (0-1.5 mM) is hydrolyzed by purified human FXIa and FXIa-LC with Km values of 225 μM and 357 μM[1].
Pyr-Pro-Arg-pNA noncompetitively inhibits human FXIa-mediated FIX activation with a Ki of 425 μM and human FXIa-LC-mediated FIX activation with a Ki of 420 μM, without altering the Km values for FIX binding to either enzyme[1].
Pyr-Pro-Arg-pNA can be hydrolyzed by purified recombinant murine activated protein C with essentially identical kinetic activity to purified human activated protein C[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 72194-57-1
-
Molecular Weight 502.52
-
Formel C22H30N8O6
-
SMILES
O=C([C@@H]1CCC(N1)=O)N2[C@@H](CCC2)C(N[C@@H](CCCNC(N)=N)C(NC3=CC=C(C=C3)[N+]([O-])=O)=O)=O
-
Synonyms
S-2366
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
-
Data Sheet (271 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Sinha D, et al. Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation. Biochemistry. 2007;46(34):9830-9839. [Content Brief]
[3]. Fernández JA, et al. Recombinant murine-activated protein C is neuroprotective in a murine ischemic stroke model. Blood Cells Mol Dis. 2003 May-Jun;30(3):271-6. [Content Brief]
[4]. Briseid K, et al. Part of purified human plasma kallikrein removed together with a remaining IgG fraction--immunoblot experiments and functional tests. Scand J Clin Lab Invest. 2002;62(1):21-24. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)